IDEXX Laboratories, Inc. Depreciation And Amortization for the Trailing 12 Months (TTM) ending March 31, 2025: USD 100.03 M

IDEXX Laboratories, Inc. Depreciation And Amortization is USD 100.03 M for the Trailing 12 Months (TTM) ending March 31, 2025, a -14.12% change year over year. Depreciation and amortization are expense that reduces the value of tangible and intangible assets over their useful lives for tax and reporting purposes.
  • IDEXX Laboratories, Inc. Depreciation And Amortization for the Trailing 12 Months (TTM) ending March 31, 2024 was USD 116.48 M, a 2.43% change year over year.
  • IDEXX Laboratories, Inc. Depreciation And Amortization for the Trailing 12 Months (TTM) ending March 31, 2023 was USD 113.72 M, a 7.23% change year over year.
  • IDEXX Laboratories, Inc. Depreciation And Amortization for the Trailing 12 Months (TTM) ending March 31, 2022 was USD 106.05 M, a 8.38% change year over year.
  • IDEXX Laboratories, Inc. Depreciation And Amortization for the Trailing 12 Months (TTM) ending March 31, 2021 was USD 97.85 M, a 8.89% change year over year.
Key Data
Date Depreciation And Amortization Dividends Paid Common Stock Issued Common Stock Repurchased